Off-Label Dissemination Promotes Illegal Activity - FDA WLF Appeal
This article was originally published in The Gray Sheet
Dissemination of information on off-label uses of medical devices and drugs is not constitutionally protected free speech because it is intended to promote illegal activities, FDA argues in its appeal of a lower court's decision in the Washington Legal Foundation v. Henney case.
You may also be interested in...
The guidance document allows manufacturers to promote their dry-heat systems for mask bioburden reduction if they meet certain standards.
The US Medicare agency is letting ambulatory surgical centers and patient homes be reimbursed as in-patient hospitals for patient care purposes during the pandemic.
The European public assessment report for Novartis's advanced breast cancer therapy, Piqray (alpelisib), includes some interesting insights into what EU regulators are looking for in drug company clinical trials.